Nu Skin Enterprises Price Target Cut to $105.00 by Analysts at Wedbush (NUS)

Share on StockTwits

Nu Skin Enterprises (NYSE:NUS) had its price target decreased by Wedbush to $105.00 in a research report sent to investors on Monday morning, StockRatingsNetwork reports.

Several other analysts have also recently commented on the stock. Analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a neutral rating to a buy rating in a research note on Monday, February 24th. Finally, analysts at Sidoti reiterated a buy rating on shares of Nu Skin Enterprises in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of Buy and a consensus target price of $102.10.

Shares of Nu Skin Enterprises (NYSE:NUS) traded up 5.54% during mid-day trading on Monday, hitting $78.74. The stock had a trading volume of 2,197,780 shares. Nu Skin Enterprises has a 52-week low of $40.15 and a 52-week high of $140.50. The stock has a 50-day moving average of $83.78 and a 200-day moving average of $103.9. The company has a market cap of $4.684 billion and a price-to-earnings ratio of 15.27. Nu Skin Enterprises also was the recipient of some unusual options trading on Monday. Traders purchased 6,848 put options on the company. This is an increase of approximately 324% compared to the typical daily volume of 1,617 put options.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Monday, March 3rd. The company reported $2.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 82.3% on a year-over-year basis. Analysts expect that Nu Skin Enterprises will post $6.38 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, March 26th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.345 per share. This represents a $1.38 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Wednesday, March 12th. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.30.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

To view Wedbush’s full report, visit Wedbush’s official website.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Royal Dutch Shell plc Given Consensus Rating of “Buy” by Analysts
Royal Dutch Shell plc Given Consensus Rating of “Buy” by Analysts
Avanir Pharmaceuticals Price Target Raised to $16.00 at Mizuho
Avanir Pharmaceuticals Price Target Raised to $16.00 at Mizuho
JMP Securities Raises Avanir Pharmaceuticals Price Target to $15.00
JMP Securities Raises Avanir Pharmaceuticals Price Target to $15.00
Deutsche Bank Upgrades Antofagasta plc to “Hold”
Deutsche Bank Upgrades Antofagasta plc to “Hold”
Babcock International Group PLC Given Consensus Recommendation of “Buy” by Brokerages
Babcock International Group PLC Given Consensus Recommendation of “Buy” by Brokerages
Scholastic Corp. Downgraded by Zacks
Scholastic Corp. Downgraded by Zacks


Leave a Reply

 
© 2006-2014 Mideast Time.